skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 26  for All Library Resources

Results 1 2 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
How to Estimate Productivity Costs in Economic Evaluations
Material Type:
Article
Add to My Research

How to Estimate Productivity Costs in Economic Evaluations

PharmacoEconomics, 2014-04, Vol.32 (4), p.335-344 [Peer Reviewed Journal]

Springer International Publishing Switzerland 2014 ;2015 INIST-CNRS ;COPYRIGHT 2014 Springer ;Copyright Wolters Kluwer Health Adis International Apr 2014 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-014-0132-3 ;PMID: 24504850

Full text available

2
Productivity Costs in Economic Evaluations: Past, Present, Future
Material Type:
Article
Add to My Research

Productivity Costs in Economic Evaluations: Past, Present, Future

PharmacoEconomics, 2013-07, Vol.31 (7), p.537-549 [Peer Reviewed Journal]

Springer International Publishing Switzerland 2013 ;2014 INIST-CNRS ;COPYRIGHT 2013 Springer ;Copyright Wolters Kluwer Health Adis International Jul 2013 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-013-0056-3 ;PMID: 23620213

Full text available

3
Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies
Material Type:
Article
Add to My Research

Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies

PharmacoEconomics, 2015-02, Vol.33 (2), p.123-135 [Peer Reviewed Journal]

Springer International Publishing Switzerland 2014 ;Copyright Springer Science & Business Media Feb 2015 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-014-0218-y ;PMID: 25315368

Full text available

4
Concerns, quality of life, access to care and productivity of the general population during the first 8 weeks of the coronavirus lockdown in Belgium and the Netherlands
Material Type:
Article
Add to My Research

Concerns, quality of life, access to care and productivity of the general population during the first 8 weeks of the coronavirus lockdown in Belgium and the Netherlands

BMC health services research, 2021-03, Vol.21 (1), p.227-227, Article 227 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1472-6963 ;EISSN: 1472-6963 ;DOI: 10.1186/s12913-021-06240-7 ;PMID: 33712010

Full text available

5
Unequal Access to Newly Registered Cancer Drugs Leads to Potential Loss of Life-Years in Europe
Material Type:
Article
Add to My Research

Unequal Access to Newly Registered Cancer Drugs Leads to Potential Loss of Life-Years in Europe

Cancers, 2020-08, Vol.12 (8), p.2313 [Peer Reviewed Journal]

COPYRIGHT 2020 MDPI AG ;2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 by the authors. 2020 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers12082313 ;PMID: 32824444

Full text available

6
Advocating uniformity in spine surgery: a practical disease-specific guideline for trial-based economic evaluations
Material Type:
Article
Add to My Research

Advocating uniformity in spine surgery: a practical disease-specific guideline for trial-based economic evaluations

BMJ open, 2023-07, Vol.13 (7), p.e073535-e073535 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2023 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2023-073535 ;PMID: 37433725

Full text available

7
Health state utilities for infertility and subfertility
Material Type:
Article
Add to My Research

Health state utilities for infertility and subfertility

Reproductive health, 2019-05, Vol.16 (1), p.47-47, Article 47 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1742-4755 ;EISSN: 1742-4755 ;DOI: 10.1186/s12978-019-0706-9 ;PMID: 31053144

Full text available

8
Multiplier Effects and Compensation Mechanisms for Inclusion in Health Economic Evaluation: A Systematic Review
Material Type:
Article
Add to My Research

Multiplier Effects and Compensation Mechanisms for Inclusion in Health Economic Evaluation: A Systematic Review

PharmacoEconomics, 2023-09, Vol.41 (9), p.1031-1050 [Peer Reviewed Journal]

The Author(s) 2023 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-023-01304-4

Digital Resources/Online E-Resources

9
Economic evaluations in European reimbursement submission guidelines: current status and comparisons
Material Type:
Article
Add to My Research

Economic evaluations in European reimbursement submission guidelines: current status and comparisons

Expert review of pharmacoeconomics & outcomes research, 2013-10, Vol.13 (5), p.579-595 [Peer Reviewed Journal]

Informa Healthcare 2013 ;COPYRIGHT 2013 Expert Reviews Ltd. ;2013 Informa Healthcare ;ISSN: 1473-7167 ;EISSN: 1744-8379 ;DOI: 10.1586/14737167.2013.837766

Full text available

10
Do Productivity Costs Matter?: The Impact of Including Productivity Costs on the Incremental Costs of Interventions Targeted at Depressive Disorders
Material Type:
Article
Add to My Research

Do Productivity Costs Matter?: The Impact of Including Productivity Costs on the Incremental Costs of Interventions Targeted at Depressive Disorders

PharmacoEconomics, 2011-07, Vol.29 (7), p.601-619 [Peer Reviewed Journal]

Springer International Publishing AG 2011 ;2015 INIST-CNRS ;COPYRIGHT 2011 Wolters Kluwer Health, Inc. ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11539970-000000000-00000 ;PMID: 21545189

Full text available

11
Healthcare utilization and costs of multiple sclerosis patients in the Netherlands: a healthcare claims database study
Material Type:
Article
Add to My Research

Healthcare utilization and costs of multiple sclerosis patients in the Netherlands: a healthcare claims database study

Journal of comparative effectiveness research, 2018-05, Vol.7 (5), p.453-462 [Peer Reviewed Journal]

2018 Quintiles IMS ;ISSN: 2042-6305 ;EISSN: 2042-6313 ;DOI: 10.2217/cer-2017-0077 ;PMID: 29775086

Full text available

12
A noticeable difference? Productivity costs related to paid and unpaid work in economic evaluations on expensive drugs
Material Type:
Article
Add to My Research

A noticeable difference? Productivity costs related to paid and unpaid work in economic evaluations on expensive drugs

The European journal of health economics, 2016-05, Vol.17 (4), p.391-402 [Peer Reviewed Journal]

Springer-Verlag Berlin Heidelberg 2016 ;The Author(s) 2015 ;ISSN: 1618-7598 ;EISSN: 1618-7601 ;DOI: 10.1007/s10198-015-0685-x ;PMID: 25876834

Full text available

13
Predicting productivity based on EQ-5D: an explorative study
Material Type:
Article
Add to My Research

Predicting productivity based on EQ-5D: an explorative study

The European journal of health economics, 2014-06, Vol.15 (5), p.465-475 [Peer Reviewed Journal]

Springer-Verlag Berlin Heidelberg 2014 ;Springer-Verlag Berlin Heidelberg 2013 ;ISSN: 1618-7598 ;EISSN: 1618-7601 ;DOI: 10.1007/s10198-013-0487-y ;PMID: 23761020

Full text available

14
Measurement and evaluation of quality of life and well-being in individuals having or having had fertility problems: a systematic review
Material Type:
Article
Add to My Research

Measurement and evaluation of quality of life and well-being in individuals having or having had fertility problems: a systematic review

The European journal of contraception & reproductive health care, 2018-11, Vol.23 (6), p.441-450 [Peer Reviewed Journal]

2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2018 ;ISSN: 1362-5187 ;EISSN: 1473-0782 ;DOI: 10.1080/13625187.2018.1539161

Digital Resources/Online E-Resources

15
Economic Evaluation of a Tumour-Agnostic Therapy: Dutch Economic Value of Larotrectinib in TRK Fusion-Positive Cancers
Material Type:
Article
Add to My Research

Economic Evaluation of a Tumour-Agnostic Therapy: Dutch Economic Value of Larotrectinib in TRK Fusion-Positive Cancers

Applied health economics and health policy, 2022-09, Vol.20 (5), p.717-729 [Peer Reviewed Journal]

The Author(s) 2022 ;Copyright Springer Nature B.V. Sep 2022 ;ISSN: 1175-5652 ;EISSN: 1179-1896 ;DOI: 10.1007/s40258-022-00740-1 ;PMID: 35843997

Full text available

16
Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands
Material Type:
Article
Add to My Research

Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands

Applied health economics and health policy, 2019-12, Vol.17 (6), p.857-873 [Peer Reviewed Journal]

The Author(s) 2019 ;Copyright Springer Nature B.V. Dec 2019 ;ISSN: 1175-5652 ;EISSN: 1179-1896 ;DOI: 10.1007/s40258-019-00500-8 ;PMID: 31444659

Full text available

17
Exploring a new method for deriving the monetary value of a QALY
Material Type:
Article
Add to My Research

Exploring a new method for deriving the monetary value of a QALY

The European journal of health economics, 2016-09, Vol.17 (7), p.801-809 [Peer Reviewed Journal]

Springer-Verlag Berlin Heidelberg 2016 ;The Author(s) 2015 ;ISSN: 1618-7598 ;EISSN: 1618-7601 ;DOI: 10.1007/s10198-015-0722-9 ;PMID: 26289341

Full text available

18
New findings from the time trade-off for income approach to elicit willingness to pay for a quality adjusted life year
Material Type:
Article
Add to My Research

New findings from the time trade-off for income approach to elicit willingness to pay for a quality adjusted life year

The European journal of health economics, 2018-03, Vol.19 (2), p.277-291 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2018 ;The Author(s) 2017 ;The European Journal of Health Economics is a copyright of Springer, (2017). All Rights Reserved. ;ISSN: 1618-7598 ;EISSN: 1618-7601 ;DOI: 10.1007/s10198-017-0883-9 ;PMID: 28275878

Full text available

19
Patient adherence to subcutaneous IFN beta-1a injections using the RebiSmart ® injection device: a retrospective real-world study among Dutch and German patients with multiple sclerosis
Material Type:
Article
Add to My Research

Patient adherence to subcutaneous IFN beta-1a injections using the RebiSmart ® injection device: a retrospective real-world study among Dutch and German patients with multiple sclerosis

Patient preference and adherence, 2017-01, Vol.11, p.1189-1196 [Peer Reviewed Journal]

COPYRIGHT 2017 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2017 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2017 Krol et al. This work is published and licensed by Dove Medical Press Limited 2017 ;ISSN: 1177-889X ;EISSN: 1177-889X ;DOI: 10.2147/PPA.S130985 ;PMID: 28744108

Full text available

20
Correction to: Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands
Material Type:
Article
Add to My Research

Correction to: Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands

Applied health economics and health policy, 2020-02, Vol.18 (1), p.141-141 [Peer Reviewed Journal]

The Author(s) 2020 ;ISSN: 1175-5652 ;EISSN: 1179-1896 ;DOI: 10.1007/s40258-019-00548-6 ;PMID: 31939112

Full text available

Results 1 - 20 of 26  for All Library Resources

Results 1 2 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2011  (4)
  2. 2011 To 2013  (5)
  3. 2014 To 2016  (5)
  4. 2017 To 2020  (8)
  5. After 2020  (5)
  6. More options open sub menu

Searching Remote Databases, Please Wait